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Abstract
Background: Recently developed Sybr Green-based in vitro Plasmodium falciparum drug sensitivity
assays provide an attractive alternative to current manual and automated methods. The present
study evaluated flow cytometry measurement of DNA staining with Sybr Green in comparison with
the P. falciparum lactate dehydrogenase assay, the tritiated hypoxanthine incorporation assay, a
previously described Sybr Green based plate reader assay and light microscopy.
Methods: All assays were set up in standardized format in 96-well plates. The 50% inhibitory
concentrations (IC50) of chloroquine, mefloquine and dihydroartemisinin against the laboratory
adapted P. falciparum strains 3D7, E8B, W2mef and Dd2 were determined using each method.
Results: The resolution achieved by flow cytometry allowed quantification of the increase in
individual cell DNA content after an incubation period of only 24 h. Regression, and Bland and
Altman analyses showed that the IC50 values determined using the flow cytometry assay after 24 h
agreed well with those obtained using the hypoxanthine incorporation assay, the P. falciparum
lactate dehydrogenase assay, the Sybr Green plate reader assay and light microscopy. However the
values obtained with the flow cytometry assay after 48 h of incubation differed significantly from
those obtained with the hypoxanthine incorporation assay, and the P. falciparum lactate
dehydrogenase assay at low IC50 values, but agreed well with the Sybr Green plate reader assay and
light microscopy.
Conclusions:  Although flow cytometric equipment is expensive, the necessary reagents are
inexpensive, the procedure is simple and rapid, and the cell volume required is minimal. This should
allow field studies using fingerprick sample volumes.
Background
In vitro parasite drug susceptibility testing has an estab-
lished role in both the evaluation of the prevalence of
drug-resistant strains of Plasmodium falciparum in endemic
areas [1-5] and screening novel compounds for anti-
malarial activity [6,7]. Historically, the most widely used
in vitro technique for assessment of drug resistance is the
microscopic quantification of parasite maturation [8]. In
this method, parasites are grown in serial drug dilutions in
96-well plates and cell suspensions from each well are
used to prepare thick blood films. The number of sch-
izonts is counted (usually per 200 parasites) after a matu-
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ration period of 20 to 40 h [9-12]. This approach is
laborious, time consuming and unpopular with micro-
scopists [13].
To circumvent these problems, light microscopic evalua-
tion as the primary assay is increasingly replaced by new
methods incorporating automated analysis of assay
plates. The most widely used are i) quantitation of triti-
ated hypoxanthine incorporated into parasite DNA by
scintillation counting [14], ii) colorimetric measurement
of Plasmodium lactate dehydrogenase (LDH) [15,16], and
iii) histidine rich protein II quantitation by Enzyme
Linked Immunosorbent Assay [17]. Recently, the feasibil-
ity of using Sybr Green (SG) nucleic acid gel stain and flu-
orescence based analysis has been investigated [18-22]. In
SG based assays, growth response is determined by detec-
tion of fluorescence using a photometric plate reader after
a 48 h incubation period. Growth and multiplication of
the parasites result in increased fluorescence signals from
the control wells compared to those in the wells contain-
ing growth-inhibiting concentrations of a drug.
Over the course of the 48 h intra-erythrocytic life cycle of
P. falciparum, the parasite develops from mono-nucleated
ring forms into multi-nucleated schizonts (Figure 1). A
schizont form is usually defined as an infected red cell
containing three or more merozoites [12]. Each merozoite
is packed with DNA and double-stranded DNA binding to
SG will contribute to the fluorescence signal from an
infected red cell. Fluorescence intensity is, therefore, a
measure of parasite maturation to the schizont stage, a
process which will be inhibited by therapeutic concentra-
tions of anti-malarial drugs.
Here, a rapid and accurate in vitro assay system based on
this principle is described, which employs a flow cytome-
ter with attached high-throughput plate analyzer. The pos-
sibility of performing drug resistance measurements
employing the technique of flow cytometry was first dem-
onstrated by van Vianen et al in 1990 [23]. Since then,
flow cytometers and software for analysis have improved
considerably, allowing faster and less complicated assays
based on flow cytometry. In the present study, a range of
different automated and manual assays for drug sensitiv-
ity, namely the tritiated hypoxanthine incorporation assay
(THA), the colorimetric measurement of Plasmodium lac-
tate dehydrogenase (LDH), the Sybr Green plate reader
assay (SGPR) and light microscopic (LM) cell count were
compared with the flow cytometry based assay (FCMA).
The assays were compared directly for up to four different
parasite strains exposed to the anti-malarial drugs chloro-
quine (CQ), mefloquine (MQ) and dihydroartemisinin
(DHA). The degree of agreement between the FCMA and
the other four assays over a range of IC50 values was
assessed using the methods of Bland and Altman [24,25]
Methods
Parasite culture
The laboratory-adapted P. falciparum strains 3D7, E8B and
W2mef were cultured in RPMI 1640 HEPES (Sigma
Examples of Plasmodium falciparum parasites (strain Dd2) at 0  h (A) 12 h (B) 24 h (C) 36 h (D) and 48 h (E) after sorbitol  synchronization under the fluorescence microscope after SG  staining (left column) and in bright field (right column) Figure 1
Examples of Plasmodium falciparum parasites (strain 
Dd2) at 0 h (A) 12 h (B) 24 h (C) 36 h (D) and 48 h (E) 
after sorbitol synchronization under the fluorescence 
microscope after SG staining (left column) and in 
bright field (right column). The images were taken from 
corresponding slides prepared at the same time point from 
the same culture and prepared either for fluorescence 
microscopy or LM. Images were obtained on a Nikon Eclipse 
TE2000 -N Microscope with a 1000 × optical magnification 
with a Nikon LH-M100CB-1 Camera.Malaria Journal 2009, 8:294 http://www.malariajournal.com/content/8/1/294
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Aldrich, St Louis, MO) supplemented with 92.6 mg/L L-
glutamine (Sigma Aldrich, St Louis, MO), 500 μg/L gen-
tamicin (Sigma Aldrich, St Louis, MO), 50 mg/L hypoxan-
thine (Sigma Aldrich, St Louis, MO) and 10% v/v pooled
human plasma (complete culture medium). Cultures
were maintained with daily changes of medium at 5%
haematocrit and diluted with red blood cells when the
parasitaemia exceeded 5%. Cultures were incubated in an
airtight desiccator cabinet at 37°C in an atmosphere con-
taining between 5% to 10% oxygen. The low oxygen
atmosphere was generated by gassing the cabinet with a
mixture of 1% O2 and 5% CO2 balanced in N2 (BOC gases,
Perth, Australia) at 1.0-1.5 bar for 60-90 s each time it had
been opened.
The parasite strains 3D7, E8B and W2mef and Dd2 exhibit
a range of drug sensitivities. 3D7 is sensitive to CQ and
MQ. W2mef and Dd2 are MQ and CQ resistant. E8B is CQ
resistant and MQ sensitive. All 4 strains are sensitive to
DHA.
The drug sensitivity assays described below required expo-
sure of parasites at the same stage of development after
merozoite invasion. This synchronization was achieved
by suspension of the cells in 5% w/v sorbitol (Sigma
Aldrich, St Louis, MO) for 12 min to allow destruction of
mature parasite stages through osmotic pressure change,
followed by re-suspension of erythrocytes containing via-
ble parasite forms in culture medium [26]. Such single-
step sorbitol synchronization produces cultures that con-
tain ring and early trophozoite stages that have developed
for up to 18 h after merozoite invasion.
Anti-malarial drugs
CQ diphosphate, MQ hydrochloride and DHA were
obtained from Sigma Aldrich (St. Louis, MO). Stock solu-
tions for CQ were prepared in distilled water, for MQ and
DHA in 70% v/v ethanol and all were stored at -20°C. On
the day of assay, aliquots were thawed and further diluted
in RPMI to make a 5 μM working standard and subse-
quent two-fold serial dilutions in complete RPMI were
performed. Final test concentrations ranged from 25 to
1600 nM for CQ, 0.78 to 200 nM for MQ and 0.1 to 51.2
nM for DHA. A set of drug dilutions was prepared in com-
plete culture medium without hypoxanthine for use in the
THA. Parasite growth response was assessed using the
assays described in the following sections. The drug con-
centrations resulting in 50% inhibition of parasite growth
(IC50) were determined by non-linear regression analysis
of the data using GraphPad Prism 4.0 (GraphPad Soft-
ware, CA).
Tritiated hypoxanthine incorporation assay (THA)
Measurement of the tritium labelled hypoxanthine incor-
porated during parasite replication can be used to deter-
mine parasite drug susceptibility [27]. These isotopic
assays were conducted at 2% parasitaemia and 1.5% hae-
matocrit. Each test was performed in triplicate. To 90 μL
red cell suspension was added 100 μL of drug-containing
medium and 10 μL of a working solution (5 mg/mL) of
tritium labelled hypoxanthine, resulting in a final activity
of 0.5 μCi/well. After 48 h incubation, the plates were sub-
jected to four freeze-thaw cycles to achieve complete cell
lysis and then harvested onto 96-well glass-fibre filtermats
(Perkin Elmer, Waltham, MA) using a Harvester 96
(Tomtec Incorporated, Hamden, CT). After air-drying, the
filtermats were sealed in plastic envelopes with 4 mL of
beta scintillant and counted on a 1450 Microbeta Plus liq-
uid scintillation counter (Wallac, Turku, Finland). Scintil-
lation counts from each well were used to derive dose
response curves.
Plasmodium falciparum lactate dehydrogenase assay 
(LDH)
Drug susceptibility assays were conducted at 1% parasi-
taemia and 1.5% haematocrit in 96 well plates with a final
well volume of 200 μL. After 48 h incubation with drug
dilutions, the plates were subjected to freeze-thaw cycles,
as above. A modification of a P. falciparum LDH detection
method was used to assess parasite growth [15,28]. The
haemolysate was homogenized by repeated vigorous
pipetting and 10 μL from each well were added to 200 μL
of Malstat solution (Trisma base 1.21 g in 90 mL deion-
ized water with pH adjusted to 9.1, 200 μL Triton X-100
(Merck, Victoria, Australia), 2 g lithium-L-lactate, 62 mg
3-acetyl-pyridine-adenine-dinucelotide (Sigma Aldrich,
St. Louis, MO), 10 μL of nitro blue tetrazolium solution
(10 mg/mL) (Sigma Aldrich, St. Louis, MO) and 10 μL
diaphorase solution (10 mg/mL) (Sigma Aldrich, St.
Louis, MO). The P. falciparum LDH reaction was allowed
to proceed at room temperature for 45 to 90 min during
which colour development in drug-free wells was
assessed. Interference by air bubbles was circumvented by
using a blow-dryer over the plate. Absorbance values in
each well at 650 nm as measured with a standard fluor-
ometer (Fluostar Optima, BMG Labtech, Offenburg, Ger-
many) were used to derive dose response curves.
Sybr Green Plate Reader Assay (SGPR)
The SGPR assay was a modification of the method
described by Smilkstein et al [20]. After 48 h incubation,
the supernatant from each well of an assay plate was
removed (approximately 200 μL) and replaced by a red
cell lysis buffer (8.26 g/L NH4Cl, 1 g/L KHCO3, 0.037 g/L
EDTA, volume 200 μL/well), which also contained Sybr
Green I at a 5× concentration. The plate was then incu-
bated at 37°C for 20 min and total fluorescence from each
well was measured on a standard fluorescence plate reader
at 520 nm (Fluostar Optima, BMG Labtech, Offenburg,
Germany). The gain of the instrument was set to a valueMalaria Journal 2009, 8:294 http://www.malariajournal.com/content/8/1/294
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of 1200. The plate was shaken in the instrument for 5 s
before reading. The absolute fluorescence values of each
well were used to generate dose response curves.
Light microscopy (LM)
A thin blood film was prepared from every drug dilution
on a well plate after an incubation time of 48 h. The films
were air dried, fixed with methanol and stained with 5%
Giemsa stain for 10 min. The number of parasites in 500
red blood cells was enumerated using standard LM tech-
niques. The parasite counts were used to derive dose
response curves.
Determination of parasite nuclear division by flow 
cytometry
Nuclear division in parasitized erythrocytes can be meas-
ured by flow cytometry. SG mainly stains the nuclei
because they contain most of the DNA (Figure 1). A syn-
chronized parasite culture was prepared for flow cytomet-
ric analysis (as described below) with sampling at the time
of synchronization and at subsequent 3 h intervals over
the next 24 h (see Figure 2). Based on the observations
from this experiment, a gating procedure was developed
which classified the cells as (1) uninfected, (2) infected
mononuclear and (3) infected multinuclear. This gating
strategy was subsequently applied in the FCMA (see Figure
3).
Flow cytometric assay (FCMA)
Drug susceptibility tests were conducted at 1% parasitae-
mia and 1.5% haematocrit with a final volume of 200 μL
per well and incubation at 37°C for a total of 48 h. After
24 h and 48 h, 10 μL of cell suspension was removed from
each well and transferred into a new plate containing 180
μL PBS per well. A 10 μL aliquot of 1:100 SG was added to
each well and the plates were incubated in the dark for 20
min. The plates were then centrifuged at 400*g for 5 min
and the supernatant was replaced with 50 μL 1% w/v para-
formaldehyde and 2.5% v/v glutaraldehyde in PBS for cell
fixation. The plates were incubated for 60 min at 4°C,
washed twice with 200 μL PBS and kept at 4°C before
being read on a FACS Canto II Flow cytometer (BD Bio-
sciences, Franklin Lakes, NJ) with attached plate coupler
in high throughput mode. The flow cell on this instru-
ment was a quartz cuvette. The light source was a 20 mW/
488 nm solid state argon laser. At the flow cell the effective
wattage of this light source is typically around 15 mW. The
laser beam had an elliptical geometry with 9 μm and 65
μm being the short and long axes of the beam profile
respectively. The instrument was equipped with photom-
ultiplier tube detectors to detect wavelengths emitted
from interaction with the the 488 nm laser in the ranges
of 750-810 nm, 670-735 nm, 610-637 nm and 564-606
nm. SG has its emission maximum at 520 nm and, there-
fore, the 564-606 nm channel was used for detection.
Fifty thousand events were acquired from each well. The
processing time for a 96-well plate was approximately 25
min. A scatter plot of forward scatter (FSC) versus fluores-
cence intensity detected in the 564-606 nm channel for
each well was automatically generated by the FACSDiva
software (BD Biosciences, Franklin Lakes, NJ) used to con-
trol the instrument. Gating was conducted using standard-
ized procedures and the FlowJo 8.7 software (Tree Star,
Ashley, OR). Tables were generated containing the frac-
tion of the total number of events detected in each of the
gates. The tabular data were further processed using a
Microsoft Excel macro, which formatted the data for sub-
sequent analysis with Graphpad Prism 4.0 (GraphPad
Software Inc.).
Since the cell volume required for the FCMA is small,
analyses at multiple time points are possible. Given the
stage at which the cultures were synchronized, a further
measurement after 48 h of incubation was made which
reflected parasite multiplication rather than maturation.
For the FCMA 24 h incubates, the response curves were
generated using the number of events corresponding to
multi-nuclear, schizont form parasites. For the 48 h incu-
bates, the drug dose response curves used the total
number of fluorescent events corresponding to all
infected cells.
Comparison of assays
All drug sensitivity tests were performed in triplicates
except for the LM assay where only a single test was per-
Parasitaemia and mean fluorescence intensity in a synchro- nized parasite culture as observed with FCM at 3 h intervals  over 24 h following synchronization (no drugs added) Figure 2
Parasitaemia and mean fluorescence intensity in a 
synchronized parasite culture as observed with FCM 
at 3 h intervals over 24 h following synchronization 
(no drugs added). While parasitaemia remains stable, the 
mean fluorescence intensity increases markedly indicating 
schizont maturation. Fluorescence intensity is expressed in 
relative fluorescence intensity units (FLU).Malaria Journal 2009, 8:294 http://www.malariajournal.com/content/8/1/294
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formed. Plates for all five methods were set up simultane-
ously from the same culture. One IC50  value was
calculated from each triplicate. The total number of tripli-
cate measurements (n) for each method/strain/drug com-
bination was as detailed below, except for the LM assay
where n corresponds to the number of single measure-
ments.
FCMA 24 h versus LDH and THA
(CQ: 3D7 n = 4, E8B n = 2, W2mef n = 3, Dd2 n = 4);(MQ:
3D7 n = 3, E8B n = 2, W2mef n = 3, Dd2 n = 4);(DHA:3D7
n = 3, E8B n = 2, W2mef n = 3, Dd2 n = 4);
FCMA 48 h versus LDH and THA
(CQ: 3D7 n = 4, E8B n = 1, W2mef n = 3, Dd2 n = 4);
(MQ: 3D7 n = 4, E8B n = 2, W2mef n = 3 Dd2 n =
4,);(DHA: 3D7 n = 4, E8B n = 1, W2mef n = 3, Dd2 n = 4);
Comparison between all assays (FCMA 24 h, FCMA 48 h, THA, LDH, 
SGPR, LM)
(CQ: 3D7 n = 2, W2mef n = 2, Dd2 n = 4); (MQ:3D7 n =
2, W2mef n = 2, Dd2 n = 4); (DHA: 3D7 n = 2, W2mef n
= 2, Dd2 n = 4);
Data analysis
Data from all five assays were analyzed using Prism 4.0
software (GraphPad Software Inc.). The datasets (scintilla-
tion counts for the THA, absorbance values for the LDH,
fluorescent event counts for the FCMA, absolute fluores-
cence for the SGPR, and parasite counts for the LM) were
normalized so that the smallest value in each dataset cor-
responded to 0% and the largest value corresponded to
100%. The normalized values were plotted over the dec-
adic logarithmically transformed drug concentrations.
Dose-response curves of the following form were fitted to
the data:
where Y corresponds to the percentage of growth at a drug
concentration X, k is the Hill slope, and IC50 is the drug
concentration causing a 50% reduction in Y. An example
for sets of dose response curves obtained from one paral-
lel assay setup for the Dd2 strain can be found in Figure 4.
Pair-wise correlations between the FCMA assay and the
other four assays were assessed using orthogonal linear
regression analyses (Deming model) to account for the
variability in both x (Method A) and y (Method B). Agree-
ment between methods was further evaluated by the
Bland-Altman method [24,25].
Results
Determination of parasite nuclear division and FCMA 
development
As in the microscopy-based schizont maturation assay,
the FCMA can enumerate parasites which have matured
after a period of time not exceeding the full intra-erythro-
cytic life cycle. In the present study, an incubation time of
24 h was used. Figure 1 illustrates the principle of flow
cytometric determination of parasite maturation based on
parasite nuclear division in infected erythrocytes in a syn-
chronized parasite culture. While there was no marked
increase in parasitaemia (number of recorded events in
the region corresponding to infected cells) over the 24 h
following synchronization, the mean fluorescence inten-
sity of the parasitized fraction of cells increased substan-
Y kI C X =
+ −
100
11 0 50 (log log ) , (1)
Scatterplots of a parasite culture directly after synchronization (panel A), the same parasite culture after 24 h of incubation  without drug (panel B) and the same parasite culture after 24 h of incubation with 1600 nM CQ (panel C) Figure 3
Scatterplots of a parasite culture directly after synchronization (panel A), the same parasite culture after 24 h 
of incubation without drug (panel B) and the same parasite culture after 24 h of incubation with 1600 nM CQ 
(panel C). In drug-treated cultures, parasites do not progress to nuclear division and remain in the lower fluorescence inten-
sity gate. Panel A also depicts the gating strategy used to distinguish between mononuclear and multinuclear parasitized cells in 
the FCMA. The number beside a gate denotes the percentage of the total events recorded in that gate.Malaria Journal 2009, 8:294 http://www.malariajournal.com/content/8/1/294
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tially, consistent with parasite maturation (Figure 2).
Events corresponding to parasitized erythrocytes fell
either into a low fluorescence intensity gate or a high flu-
orescence intensity gate depending on the fluorescence
intensity of the DNA content. The number of events
recorded in the high fluorescence intensity gate after an
incubation time of 24 h corresponds to the number of
multinucleated schizonts, which have developed over that
time.
The scatterplots in Figure 3 show an initially synchronized
parasite culture of clone 3D7 (panel A), the same parasite
culture after 24 h without drug (panel B), and the same
parasite culture after 24 h incubation with an inhibitory
concentration of CQ (panel C). The untreated parasite
culture developed during incubation, resulting in a higher
percentage of infected cells in the high fluorescence inten-
sity gate. By contrast, the parasites in the culture contain-
ing CQ did not develop and the vast majority of recorded
events corresponding to infected cells remained in the low
fluorescence intensity gate. When incubating parasites
with different concentrations of drug, the percentage of
cells recorded in the high fluorescence intensity gate is,
therefore, a measure of drug action and batch processing
of the scatterplots obtained from a well plate analysis can
be used to generate drug response profiles.
Normal development of synchronized P. falciparum
results in stepwise multiplication at 48 h intervals. There-
fore, the number of infected cells increases without drug
pressure but remains the same when exposed to inhibi-
tory drug concentrations. Thus the scatterplot after 48 h of
incubation yields information regarding the effect of the
drug on parasite multiplication.
Comparison of FCMA, THA and LDH, SGPR and LM
The differences in absolute IC50 values between methods
were not normally distributed (as assessed by the Kol-
mogorov-Smirnoff test), but logarithmic transformation
produced values that were normally distributed about
their mean. Therefore, for orthogonal linear regression
and Bland-Altman analysis the logarithms of the IC50 val-
ues were used. Figure 5 shows the results of the orthogo-
nal linear regression analysis of pair-wise comparisons of
the IC50 measurements obtained from the FCMA assays
with those from the other four assays. Results obtained
using the Bland-Altman method are shown in Table 1 and
Figure 6. All assays produced similar IC50 values after 24 h
of incubation over the full concentration range used in the
present study. The FCMA-derived IC50  values at 48 h
tended to be lower than those of the THA and LDH at drug
concentrations <10 nM. However the FCMA at 48 h corre-
sponded well with the SGPR and LM methods.
Discussion
Based on regression and Bland-Altman analyses, the
FMCA performed well when compared with the other
four in vitro assays of P. falciparum drug sensitivity, espe-
cially when restricted to a 24 h incubation. Parasite forms
in the second half of the life cycle are not seen in blood
taken from patients with falciparum malaria since eryth-
rocytes containing these mature parasite forms cytoadhere
within the microvasculature. Thus, prior synchronization
of field samples appears unnecessary.
The discrepancies between FMCA at 48 h and the THA and
LDH at low drug concentrations may relate to the nature
of the assays. Whereas the LDH and THA measure parasite
metabolic activity on a continuous scale, the fluorescence
based assays measure parasite metabolic activity 'step-
wise' with the signal increasing only if new nuclei are
formed. It may be that lower drug concentrations still
allow a degree of parasite metabolic activity, which is not
measurable with fluorescence based assays because it does
not result in a nuclear division.
Representative dose response curves for a set of parallel assays using the Dd2 strain Figure 4
Representative dose response curves for a set of parallel assays using the Dd2 strain. Panel A shows the 
responses measured by the different methods to CQ, Panel B to MQ and Panel C to DHA.Malaria Journal 2009, 8:294 http://www.malariajournal.com/content/8/1/294
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Orthogonal linear regression (Deming model) for pair-wise comparison of the different assays Figure 5
Orthogonal linear regression (Deming model) for pair-wise comparison of the different assays. Panel A: FCMA 
at 24 h and THA, Panel B: FCMA at 24 h and LDH, Panel C: FCMA at 24 h and SGPR, Panel D: FCMA at 24 h and LM. 
Panel E: FCMA at 48 h and THA, Panel F: FCMA at 48 h and LDH, Panel G: FCMA at 48 h and SGPR, Panel H: FCMA at 
48 h and LM The solid black lines are the best fit lines of the regression. The dashed grey lines represent the line of identity. 
Regression equations are given with each plot together with the 95% confidence intervals on the fitted parameters.Malaria Journal 2009, 8:294 http://www.malariajournal.com/content/8/1/294
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Bland Altman plots displaying the differences between individual measurements of IC50 (as described in the methods section)  using different pairs of techniques Figure 6
Bland Altman plots displaying the differences between individual measurements of IC50 (as described in the 
methods section) using different pairs of techniques. Panel A: FCMA at 24 h and THA, Panel B: FCMA at 24 h and 
LDH, Panel C: FCMA at 24 h and SGPR, Panel D: FCMA at 24 h and LM, Panel E: FCMA at 48 h and THA, Panel F: FCMA 
at 48 h and LDH, Panel G: FCMA at 48 h and SGPR, Panel H: FCMA at 48 h and LM. The differences in logarithmically trans-
formed IC50 values for a paired measurement are plotted over the logarithmically transformed averages of the paired measure-
ments. The inner dotted line is the average difference of the IC50 values while the outer dotted lines denote the upper and 
lower 95% limits of agreement between the two techniques.Malaria Journal 2009, 8:294 http://www.malariajournal.com/content/8/1/294
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The FCMA has several advantages over the other methods.
Although the flow cytometric equipment is expensive and
available only in specialized centres, the necessary rea-
gents are inexpensive (approximate cost US$1.50/96 well
plate). Accurate results from FCMA were obtained after an
incubation time of 24 h. This contrasts with the usual 42
h used with THA assays [4,14,29-31], and 48 h for both
the LDH and other assays based on SG [15,20-22]. The LM
assay can be evaluated after 24 h incubation. However,
LM is very labour-intensive.
After incubation, processing and flow cytometry can also
be performed rapidly in the FCMA technique, with the
high-throughput coupler being able to process a 96 well
plate in about 25 min. By comparison, the assay as
described by van Vianen 1990 [23] required 2 h for plate
reading. In the present study, cells were fixed, which
requires additional washing and incubation steps. How-
ever, once the cells are fixed, the plates can be kept for up
to several weeks before being analysed. In laboratories
where cell fixation is not required prior to flow cytometry,
addition of the fluorescent dye, a short incubation period
and subsequent flow cytometry may be sufficient to
obtain valid results, reducing the processing time to a few
minutes.
Another advantage of the present FCMA method is that it
allows a basic assessment of stage specific drug sensitivity.
Although it can only distinguish between parasites con-
taining a single nucleus and multiple nuclei, the present
data show that development of the parasites is slowed but
not stopped at certain drug concentrations. While this
effect was not seen at 24 h, it became evident at 48 h using
the FCMA. Parasites exposed to drug concentrations at
least twice those which inhibited reinvasion still devel-
oped into multi nucleated forms in 48 h. The delay in par-
asite maturation becomes evident when looking at the
ratio between single nucleated and multinucleated para-
site forms in the test wells as shown in Figure 7.
A further advantage is the relatively small number of cells
required for the FCMA. In the present study, FCMA plates
were set up at 1.5% haematocrit and small volumes (10
μL/well) were removed from the original plates and sus-
pended in 190 μL/well PBS in new 96 well plates. This
procedure resulted in a final cell concentration of about
7.5 × 103 μL-1. This enables serial FCM analyses from the
same 96 well plate, for example where duration of drug
exposure is of interest. With the very low cell number
required, it is possible to set up the FCMA using a very low
initial haematocrit so that the volume of blood obtaina-
ble from a fingerprick would be enough to set up an entire
96-well plate.
There are potential sources of interference with the FCMA
system. Although white blood cells in an unprocessed fin-
gerprick sample exhibit much higher fluorescence than
malaria parasites, they can easily be gated out. In the
present study, the culture medium was supplemented
with human serum that caused some background noise in
the flow cytometric measurements. However, if human
serum is substituted by Albumax II (Invitrogen, Carlsbad,
CA) this can be completely abrogated.
Several assays have been developed, many of them very
recently, employing flow cytometry to measure parasite
drug resistance[23,32-35]. The FCMA presented here has
advantages when compared with all these assays. All but
one of the previous studies have used 42 h-48 h incuba-
tion periods. Also, only a few of these studies used a high
throughput flow cytometer. The present assay combines
the advantages of previous assays. It uses a simple, inex-
pensive single staining procedure without cell lysis, and
allows stage specific discrimination of malaria parasites
and high throughput measurement after short incubation
time (24 h). The present study is the first to compare flow
cytometric measurement of parasite maturation after 24 h
with four established reference methods.
Recently, Izumiyama et al [33] presented preliminary data
on an FCM assay measuring drug resistance after 25 h of
incubation using Sybr Green. The study was focused on
the basic principles of stage discrimination by Sybr Green
based on flow cytometry but did not use high throughput
flow cytometry. Even more recently, a study by Grimberg
et al [32] used a sophisticated well plate based flow cytom-
etry assay with a combination of dyes to discriminate
between DNA and RNA and determine life cycle stages.
Table 1: Geometric means and (lower and upper 95% limits of agreement) in log [nM] for the differences in IC50s between the 
methods
FCMA (48 h) FCMA(24 h) THA LDH SGPR
FCMA (24 h) 0.18 (-0.79, 1.15) - - - -
THA -0.24 (-1.16, 0.68) -0.07 (-0.80, 0.66) - - -
LDH -0.19(-1.38, 0.99) 0.003 (-0.80, 0.79) 0.07 (-0.85, 1.00) - -
SGPR -0.04 (-0.72, 0.68) 0.01 (-.0.55, 0.56) -0.18 (-0.81, 0.45) 0.08 (-0.51, 0.67) -
LM 0.13 (-0.37, 0.63) 0.18 (-0.33, 0.68) -0.36 (-1.06, 0.35) -0.09 (-0.77, 0.58) 0.17 (-0.33, 0.68)Malaria Journal 2009, 8:294 http://www.malariajournal.com/content/8/1/294
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While Grimberg's method may allow for more differential
stage discrimination, since RNA was measured as a sepa-
rate parameter, this method is more complicated, and
requires more expensive equipment such as a multi-laser
flow cytometer with at least one laser in the UV range.
Conclusion
Flow cytometry based measurement of fluorescence from
SG stained cell samples provides a method of rapidly and
accurately analyzing the drug sensitivity of P. falciparum in
vitro. Although not yet available in many laboratories in
developing countries, the technology may become more
affordable in the near future. The relative ease of the assay,
its potentially high throughput and the low reagent costs
once the system is established could enable large-scale
assessment of local parasite resistance patterns as well as
facilitate screening of much-needed new anti-malarial
compounds.
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